Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
contrast agent |
| gptkbp:activeIngredient |
gptkb:gadoxetate_disodium
|
| gptkbp:approvalYear |
2008
|
| gptkbp:ATCCode |
V08CA10
|
| gptkbp:chemicalFormula |
C23H28GdN3Na2O11
|
| gptkbp:contraindication |
severe renal impairment
|
| gptkbp:eliminationHalfLife |
0.75 hours
|
| gptkbp:excretion |
renal
biliary |
| https://www.w3.org/2000/01/rdf-schema#label |
Eovist
|
| gptkbp:imagingModality |
MRI
|
| gptkbp:indication |
detection of liver lesions
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Bayer
|
| gptkbp:otherName |
gptkb:Primovist
gptkb:gadoxetate_disodium |
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:riskFactor |
gptkb:nephrogenic_systemic_fibrosis
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
nausea
headache injection site reaction |
| gptkbp:usedFor |
magnetic resonance imaging
liver imaging |
| gptkbp:bfsParent |
gptkb:Primovist
|
| gptkbp:bfsLayer |
7
|